Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2020 | Neoadjuvant approaches in melanoma

Alexander van Akkooi • 14 Oct 2020
EADO 2020
Melanoma Skin Cancer

Alexander van Akkooi, MD, PhD, Netherlands Cancer Institute, Amsterdam, The Netherlands, gives an update on neoadjuvant approaches in treating melanoma. Dr Akkooi discusses the benefits of neoadjuvant immunotherapy and targeted therapy. This is interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Alexander van Akkooi

1:43
Real-world analysis of T-VEC for melanoma
Alexander van Akkooi • 19 Apr 2021
2:27
Serum NSE levels as a biomarker in MCC
Alexander van Akkooi • 19 Apr 2021
2:38
Sentinel node tumor burden for prognostication in melanoma
Alexander van Akkooi • 19 Apr 2021
2:41
Immunotherapies for satellite or ITM melanoma
Alexander van Akkooi • 19 Apr 2021

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals